DOUGLAS B GIVEN
CIK 1156207 · last filed 2024-12-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.23M
Companies
2
Total Filings
41
Lifetime Open-Market Net
-$5.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Director | 137,214 | $74.52 | $10.23M | -$5.31M | 37 | 2024-12-18 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Director | 122,867 | — | — | $0 | 2 | 2009-03-16 |
Recent Filings · Page 2 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-24 | ARWR | Sell (S) | −1,125 | -$99.8K | EDGAR |
| 2021-01-19 | ARWR | Sell (S) | −3,000 | -$249.8K | EDGAR |
| 2021-01-05 | ARWR | Mixed | +5,500 | -$304.3K | EDGAR |
| 2020-12-29 | ARWR | Gift (G) | −870 | $0 | EDGAR |
| 2020-12-18 | ARWR | Mixed | −9,575 | -$759.4K | EDGAR |
| 2020-04-16 | ARWR | Mixed | −26,112 | -$922.2K | EDGAR |
| 2020-01-03 | ARWR | Grant (A) | +8,000 | $0 | EDGAR |
| 2019-02-26 | ARWR | Mixed | −3,000 | -$1.05M | EDGAR |
| 2019-01-24 | ARWR | Sell (S) | −3,000 | -$40.7K | EDGAR |
| 2019-01-03 | ARWR | Grant (A) | +36,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.